Growth Potential With its recent funding and a revenue range of 50 to 100 million USD, Panacela Labs presents an attractive opportunity for partnerships aimed at expanding biotech research, clinical development, and innovative oncology solutions.
Strategic Collaborations The company's history of joint ventures and collaborations with renowned research institutes highlights opportunities to leverage its network for co-development projects, licensing deals, and strategic alliances in the biotech sector.
Technological Infrastructure Utilizing diverse tech stacks such as MySQL, PHP, and cloud services indicates a strong foundation for data management and digital research solutions, making it a potential client for advanced biotech software, data analytics, and cloud computing services.
Market Segment Focus Specializing in oncology and orphan drugs, Panacela Labs offers targeted growth avenues to suppliers of specialized research tools, clinical trial services, and personalized medicine solutions aligned with niche biotech and pharmaceutical markets.
Competitive Positioning As a mid-sized player in the biotech research industry, Panacela Labs is positioned to benefit from market expansion trends and can be engaged through customized value propositions that differentiate its offerings in rapidly evolving biomedical research landscapes.
$10B
$1B$10B
$1B$10B
$1B$10B
$10B
$25M$50M
$10B
$1B$10BPanacela Labs, Inc. uses 8 technology products and services including MySQL, Google Workspace, Twemoji, and more. Explore Panacela Labs, Inc.'s tech stack below.
| Panacela Labs, Inc. Email Formats | Percentage |
| FLast@panacelalabs.com | 100% |
Biotechnology ResearchNew York, United States11-50 Employees
Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “RUSNANO”, the largest Russian investment company, in collaboration with Roswell Park Cancer Institute, Children’s Cancer Institute of Australia and Cleveland Clinic Foundation.
Company Overview
Funding & FinancialsPanacela Labs, Inc. has raised a total of $2.9M of funding over 2 rounds. Their latest funding round was raised on Dec 24, 2015 in the amount of $2.9M.
Panacela Labs, Inc.'s revenue is estimated to be in the range of $50M$100M
Funding & FinancialsPanacela Labs, Inc. has raised a total of $2.9M of funding over 2 rounds. Their latest funding round was raised on Dec 24, 2015 in the amount of $2.9M.
Panacela Labs, Inc.'s revenue is estimated to be in the range of $50M$100M
1-888-653-2347 
support@leadiq.com